Peptide CMC (Chemistry, Manufacturing, and Controls) development refers to the research and development work on the chemical, manufacturing, and quality control aspects of peptide drugs. CMC development is an important part of the drug development process, aimed at ensuring the quality, safety, and efficacy of peptide drugs.
Commercialization of API refers to the process of bringing the developed Active Pharmaceutical Ingredient (API) to the market and commercializing its production. API is the active ingredient in drugs that has therapeutic effects and is an essential component in the pharmaceutical process.
Functional peptides are short chain protein molecules with specific biological functions. Due to their extensive bioactivity, biocompatibility and stability, functional peptides have great potential applications in drug development, food raw materials and biological materials.
Peptide discovery services refer to the professional services provided to clients for the discovery and design of peptide drugs. These services are typically offered by biotechnology companies, drug development organizations, or specialized peptide discovery companies.
